ASSOCIATION OF SGLT2 INHIBITORS WITH STROKE IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引:0
|
作者
Mi, D. [1 ]
Pan, P. [1 ]
Chen, S. [1 ]
Chen, S. [1 ]
Peng, F. [1 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
SO067 / #
引用
收藏
页码:88 / 88
页数:1
相关论文
共 50 条
  • [11] SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis
    Seidu, Samuel
    Kunutsor, Setor K.
    Cos, Xavier
    Gillani, Syed
    Khunti, Kamlesh
    PRIMARY CARE DIABETES, 2018, 12 (03) : 265 - 283
  • [12] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Tang, Huilin
    Dai, Qi
    Shi, Weilong
    Zhai, Suodi
    Song, Yiqing
    Han, Jiali
    DIABETOLOGIA, 2017, 60 (10) : 1862 - 1872
  • [13] Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis
    Jiali Liu
    Ling Li
    Sheyu Li
    Pengli Jia
    Ke Deng
    Wenwen Chen
    Xin Sun
    Scientific Reports, 7
  • [14] Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis
    Liu, Jiali
    Li, Ling
    Li, Sheyu
    Jia, Pengli
    Deng, Ke
    Chen, Wenwen
    Sun, Xin
    SCIENTIFIC REPORTS, 2017, 7
  • [15] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Huilin Tang
    Qi Dai
    Weilong Shi
    Suodi Zhai
    Yiqing Song
    Jiali Han
    Diabetologia, 2017, 60 : 1862 - 1872
  • [16] Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
    Zheng, Ru-Jie
    Wang, Yue
    Tang, Jun-Nan
    Duan, Jie-Ying
    Yuan, Ming-Yue
    Zhang, Jin-Ying
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 145 - 152
  • [17] The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
    Chen, Jiao
    Fan, Fang
    Wang, J. Y.
    Long, Yang
    Gao, C. L.
    Stanton, R. C.
    Xu, Yong
    SCIENTIFIC REPORTS, 2017, 7
  • [18] The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
    Jiao Chen
    Fang Fan
    J. Y. Wang
    Yang Long
    C. L. Gao
    R. C. Stanton
    Yong Xu
    Scientific Reports, 7
  • [19] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Wen-jie Li
    Xing-qing Chen
    Ling-ling Xu
    Yuan-qing Li
    Bi-hui Luo
    Cardiovascular Diabetology, 19
  • [20] Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
    Hegde, Naveen C.
    Kumar, Ankit
    Patil, Amol N.
    Bhattacharjee, Samiksha
    Gamad, Nanda
    Kasudhan, Kripa Shanker
    Kumar, Vivek
    Rastogi, Ashu
    ACTA DIABETOLOGICA, 2023, 60 (10) : 1311 - 1331